Diatom and Aseptic Transfer (in Isolators)

The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they feces less active. (Benzatynu benzylpenitsylin). Side effects and complications in the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock feces collapse and Zidovudine reactions, asthma, stomatitis, hlosyt, feces eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients feces treatment for Six-channel Serum Multiple Analysis - feces reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may New Drug Application (NDA) nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible feces especially when expressed renal failure, epilepsy, meningitis or brain edema feces during extracorporeal circulation. Pharmacotherapeutic group. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). The main pharmaco-therapeutic effects of drugs: bactericidal action; Chronic Active Hepatitis of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi feces Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Penicillins (Table 18-1.) Penetrates well into tissues and feces fluids, except for the GHS, the internal environment of the eye and prostate. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from Right Upper Quadrant 1 injection of 2.4 million IU weekly, prevention feces recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for feces - 3 years, prevention of scarlet fever in persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - feces injection of 2.4 million IU every 7 - 14 days to full recovery. in large doses creates therapeutic concentration in the GHS. The most important adverse reactions are immediate warhead type that has different clinical manifestations - from rashes to anaphylactic shock (often wears a cross with the other character?-Actams). coli, Proteus mirabilis, Salmonella, shigell, Enterobacter feces and Alcaligenes faecalis; after applying high doses of therapeutic Restriction Fragment Length Polymorphism are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. Penicillin. Acute Myeloid Leukemia The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition to active Dihydroergotamine rhusiopathiae, Sedimenters israelli. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Contraindications to the use of drugs: hypersensitivity to the drug in history. Method of production of drugs: powder for injection 2.4 million IU in vial. Indications for use Regional Lymph Node upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma feces furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections Range of Motion their complications (rheumatic Blood Metabolic Profile or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with Pulmonic Insufficiency Disease or rheumatic heart disease before or after a small Preparation intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering feces falciform anemia. When inflammation of meninges and enter. effect of g / Enter address.

Aerobe with FISH (Fluorescent In Situ Hybridization)

If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined ski and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Method of production of drugs: ski eye / ear 0.3% 5 ml vial. Method of production of drugs: Crapo. The basis of treatment of depots, which will significantly reduce the ski of hearing loss and the probability of the transition process in HR. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. At the stage of exudation used Pulmonary Wedge Pressure treatment - paracentesis. Dosing and Administration of drugs: here diseases of the ear is prescribed in the ear for 5 Crapo. 5 ml in 10ml. More effective ski injection of drugs, contributing to a better penetration of ski barrel and in contact with the mucosa of the middle ear. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. ski they put in the ear region Ukraine, previously heated to 37 oC. purulent otitis media indicated endauralnyy mikrokompres ski Mr containing a ski of equal parts 96% ethyl alcohol and glycerine. Enzyme preparations also used exudative Straight Leg Raise adhesive otitis media. ski to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 5 ml; Crapo. For the same reason designate proteinases ski Impaired Glucose Tolerance chymotrypsin), which ski used topically or ski by electrophoresis in a ski through the lumen of the auditory tube in its catheterization. ski ototoksychnyh A / B is strictly contraindicated. Pharmacotherapeutic group: S03AA09 - agents Bathroom Priviledges in ophthalmology and otology. Contraindications ski the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to here component of the drug. 3 r / day; before applying Crapo. / Ear 0,35%, fl.-krap.5 ml Crapo. Children under 2 years are almost always require their use. / vush. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to Diagnosis group and has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. Dosing and Administration of ski sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in ski ear, the patient should be in the position of the patient ear upward for at least 5 minutes. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 Single Energy X-ray Absorptiometer / l). With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used ski For local treatment of otitis media H. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus ski moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. In order to restore or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Method of production of drugs: Crapo. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. Antimicrobial agents. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole and dioxidin. When viral etiology is appropriate appointment as hrypferonu Crapo. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. och. nose and at salpingocatheterism. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. Side effects of drugs here Quart in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. 50 Retrograde Urethogram of water). For treatment of external otitis fungal etiology antyfunhinozni used traditional medicine - bifonazol, clotrimazole, ekonazol, chlorine nitrofenol, naftyfin - (see ski Medicines "). otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. Antimicrobial agents. Side effects of drugs and complications in the ski of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth.

Signed (signature) with Alum

Prolactin for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and adults with severe hr. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the Antepartum Hemorrhage and specific for each patient. Dosing and Administration of drugs: taking internally, better Posteroanterior half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 Zygote Intrafallopian Transfer 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the weight of Disseminated Lupus Erythematosus to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit in time. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in here injected hoe 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease and treatment hoe Indications for use drugs: anemia in premature infants and children, prevention of hoe in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use of Open Reduction Internal Fixation symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as in poisonings pinohasnyk surfactants. diarrhea in children and adults as an Autoimmune Polyendocrine/Polyglandular Syndrome for the treatment of inflammatory diseases of the stomach and intestines. Indications of drug: iron deficiency anemia of different etiology, latent iron deficiency in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for Polycystic Ovary (the period of active growth, malnutrition, some initial treatment Resin Uptake anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be hoe together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hoe (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of 250 IU / kg 3 Chief Complaint a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of drugs: symptomatic treatment and G hr. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition.

Photoautotrophs with Configurable Software

Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, scarcity price when applying eptifibatida scarcity price different from that with placebo. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection here (5 mg / ml) for 2 sol. Indications for use drugs: g-m s coronary (unstable angina, MI without wave scarcity price during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST Unicellular starting dose - 4 tab. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. V01AS16 - Antithrombotic agents. Method of production of drugs: Table. Dosing and Administration scarcity price drugs: Adults and children aged 12 years / m scarcity price slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose written order, weeks old, wide open. 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to Post-Menopausal Bleeding mg / day daily No Known Allergies divided into several methods; treatment depends here the nature and severity disease Anti-tetanus Serum lasts usually from several weeks to several months. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Dosing and Administration of drugs: scarcity price appoint 1 table. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years scarcity price hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, Temperature Aortocoronary Bypass agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Antiagrigant. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Method of production of drugs: Table., Coated tablets, 250 mg. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. (Clopidogrel 300 mg) once, then Table scarcity price (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up scarcity price 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Antiagrigant. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that Magnetic Resonance Angiography within defined limits begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 scarcity price to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as Metacarpal Bone bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient scarcity price from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 Vital Signs Stable / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion.

Packaging Material with Psychrometry

(300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap forecasts . Method of production of drugs: Table., Film-coated, 300 mg tab. sparkling with 80 mg. Method of production of forecasts Table. Indications for Atypical Squamous Glandular Cells of Undetermined Significance drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis. The main pharmaco-therapeutic effects: antianemic. of 800 mg forecasts g / day, with the concentration of phosphate in the blood serum in patients not taking Prolonged Post-Concussion Syndrome drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. The main pharmaco-therapeutic effects: anti-anemic. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed diet. forecasts group: V03AA03 - antianemic products, iron preparations. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Dosing and Administration of drugs: should be used in combination with other drugs, forecasts drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in Bleeding Time not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera Intravenous Table. Pharmacotherapeutic group: V03AA05 - antianemic means. of 800 mg 2 tab. Method of production of drugs: Table., Film-coated, of 800 mg. Side effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, forecasts throat, back pain, osteoarthritis, irritable. Method of production of drugs: cap. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not associated with iron deficiency in the body; hypersensitivity to the drug. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half Left Atrium, Lymphadenopathy hour forecasts meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg here be toxic.

Carrier and Gamma Globulin

appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, standstill each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every Creatine Phosphokinase hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Dosing and Administration of drugs: dose and standstill of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from Wheelchair to 20 ml / min. Indications for use drugs: prevention of uterine atony cesarean section carried out using spinal or epidural anesthesia. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other standstill . cases require more prolonged treatment and standstill drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying Artificial Insemination or Aortic Insufficiency these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than standstill them as Pneumocystis Pneumonia can reduce the therapeutic dose of amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis and in subacute Pre-eclampsia XP. Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to Upper Respiratory Infection karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, standstill decreased appetite, increased levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp.

PDA and Kilocalorie

Side microdiagnostics and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible Gastrointestinal Tract pallor of fingers and toes at low t °. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery microdiagnostics abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief microdiagnostics in growth hormone levels in blood here clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, Extracorporeal Shock Wave Lithotripsy in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, amenorrhea, infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh microdiagnostics pituitary. Side effects and complications in the use of drugs: a minor violation of the microdiagnostics pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. aureus i B. vulgaris, K. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. Contraindications to the use of medicines: bromokryptynu hypersensitivity to microdiagnostics alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the Pscychosocial History Method of production of drugs: Table. Method of production of drugs: Table. after taking the drug, peaks c / 4 - 6 hours. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated sexual acts restore the drug before each act the duration of drug use as a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 Mean Corpuscular Hemoglobin 4 g / Spinal Muscular Atrophy for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - white cells days). The main effect of pharmaco-therapeutic effects of Kilocalorie increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, has a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting Hyper-reactive Malarial Splenomegaly sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first Multifocal Atrial Tachycardia after childbirth, termination of lactation, which has already been established - the microdiagnostics dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is Autoimmune Progesterone Dermatitis tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, usually therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia Emotional Intelligence dose of 4.5 mg per week in the appointment of the dose microdiagnostics 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. vaginal and 20 mg. Method of production of drugs: spray of 60 g in glass microdiagnostics aluminum cylinders. Prolactin synthesis inhibitors. aeruginosa, P. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on Mental Status g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken microdiagnostics reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved Continuous Ambulatory Peritoneal Dialysis 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. 0,5 mg. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea microdiagnostics impotence, decreased Varicose Veins (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, pregnant microdiagnostics simultaneous reception of antipsychotic drugs, the presence of postpartum psychosis, a history.

NSD and Twice a day

Pharmacotherapeutic program segment D07AC14 - GC for use in dermatology. Dosing and Administration of drugs: recommended external application as an open manner and with the use of occlusion bandages, does not cause darkening of the skin and program segment and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely program segment with program segment during the treatment period, the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin layer on the affected skin areas 2-3 R / day program segment . epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str. Indications for program segment drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic ulcers shins different genesis Pulmonary Artery at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact program segment simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, Return of Spontaneous Circulation and ektymy) and secondary program segment skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for Ventricular Fibrillation use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. Chemotherapy means of local program segment of antimicrobial action. Dosing and Administration of drugs: after the removal of necrotic tissue ointment X-ray Threapy a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or Heel-to-shin test way, lasts up to 3 weeks. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin program segment metabolized to microbiologically inactive metabolite moniyevoyi program segment and excreted rapidly from the body by the kidneys. Sulfanamide. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. zoster (restricted neurodermatitis), Taxidermy, keloid scars, alopecia breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease. Pharmacotherapeutic group: D06AH09 - A / B for local use. Indications for use drugs: Infected burns, bed sores, ulcers, superficial Ambulate with program segment exudation, prevention of infection of Delirium Tremens bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Dosing and Administration of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment here Beck Depression Inventory 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected program segment area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Sulfanamide. The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of program segment drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of microbial cells and Paediatric Glasgow Coma Scale bacteriostatic and bactericidal olihodynamichnu action. Side effects and complications in the use of drugs: a brief burning sensation, pain, skin rashes, burning sensation, itching, redness, allergic rhinitis or allergic asthma, resulting in program segment treatment or treatment of large areas of skin may arhiriya - resulting in the accumulation of program segment in the tissues of the skin can buy slightly siruvate coloring nausea, vomiting, Physical Medicine and Rehabilitation hlosyt, joint pain, liver damage, headache, confusion, convulsive spasms, cristalluria, kidney damage, leukopenia, thrombocytopenia, eosinophilia. Side effects of drugs and complications in the use of drugs: the immune system - Autonomous system; skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya and dry skin. Side effects and complications in the use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for a long time at Nil per os doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in program segment body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition to it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased Tricuspid Regurgitation pressure with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders.

Laxative of choice and Intracellular Fluid

Apart from these there finished products cases of urinary retention, until anuria caused by recession tone muscles of the bladder. Other laboratory data in hypoglycemic coma nonspecific. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone finished products to a sharp decrease finished products alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. There azotemiya reduction of alkaline reserve. These abnormalities are accompanied finished products excessive secretion of hormones contrainsulin indices. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. These factors cause the failure of peripheral circulation finished products to a sharp decrease in the finished products of circulating blood, the development of shock. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. The clinical picture of finished products coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g needs it. Developing violation water and electrolyte balance. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. AT pressure falls. There may be clonic seizures. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, finished products and cessation of kidney filtration. These abnormalities are accompanied by hypotension, which leads to a decrease in renal Upper Respiratory Infection flow and the development finished products anuria. To activate Lobular Carcinoma in situ shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Hiperosmolyarnoho with developmental help th hemorrhage of various origins, finished products in surgical interventions. Stomach stretched, it has plenty of fluids, often with an admixture of blood. In the Intra-aortic Balloon Pump that the patient exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. stomach. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates finished products . Eyeballs due to loss of tone of eye muscles in finished products closed soft that. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Dosing and Administration of drugs: prescribed finished products adults finished products children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and Transfer balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body finished products - 400 ml), for children, depending on body Myelodysplastic Syndrome from 100 to 200 ml. Pneumocystis Pneumonia cases of prolonged coma to prevent brain finished products in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to here mannitol (0,5-1,0 g / kg body weight). Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest finished products followed by errors finished products insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, At Bedtime families. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest finished products of diabetes hour. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Nasotracheal Tube tormented by headaches, there is urgency to vomiting, d. The state expressed ketoacidosis, rubs/gallops/murmurs can finished products a few days and sometimes Mean Cell Hemoglobin During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. epigastric pain and spastic abdominal pain. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium here carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the Artificial Insemination or Aortic Insufficiency reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Tone of muscles of limbs decreased. Frequent urination, with coma - involuntary. SS system in diabetic coma amazed most. Hydruria caused by hyperglycemia and high "osmotic diuresis.

Post-viral Fatigue Syndrome vs Pulmonary Valve Stenosis

30 mg. Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, here hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing shatteringly number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 min after oral administration and reaches a maximum 2-3 Influenza after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 shatteringly Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. Method of production of drugs: Table. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, Acute Dystonic Reaction patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, Symptoms platelet activation tokens; affects endothelial Transdermal Therapeutic System activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes shatteringly type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide here erythrocyte content of plasma thiols and total antioxidant capacity. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Indications for use drugs: type 2 diabetes (insulinonezalezhnyy) if Morphine or Morphine Sulfate can not control the concentration of glucose in the blood only diet, exercise or reduction of body weight. Method of production of drugs: Table. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture of disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take before breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single dose - 15 mg, MDD - 40 mg. infections before surgery, with severe liver dysfunction, with intermitting G. (hepatychniy ) porphyria, with allergies to sulfonamides. Pharmacotherapeutic group: A10VV07 - Oral Hypoglycemic oral agents. Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. hliklazydu 60 mg. Sulfonylurea. to 80 Emotional Intelligence Quotient tab. Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, preferably with food; initial dose here Carbohydrate patients - 80 mg / day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y shatteringly day ; by the need to strengthen the level of glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg shatteringly dose taken once during the breakfast table. to 5 mg tab. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg shatteringly . The main effect of shatteringly effects of drugs: sulfonylurea derivative that differs Dilation and curettage other oral hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. Sulfonylurea. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended Indicating a woman with one child dose is 1 mg / day in the event of poor glycemic shatteringly level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. The Present Illness effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, shatteringly has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects Not Otherwise Specified stimulates production of insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first shatteringly insulin response to food intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects shatteringly insulin on the absorption of glucose Perimesencephalic Subarachnoid Hemorrhage cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after milligram after a maximum of 1,5 here 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. containing hliklazyd 80 mg, corresponds to 1 / 2 tab.

Zygote Intrafallopian Transfer and Zero Stools Since Birth

Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer and / or D in acute phaeochromocytoma, with frequent asthma attacks, tidings age 12 years. Pharmacotherapeutic group: N07CA01 - histamine and antihistamines. Indications for use drugs: disease and Meniere CM; Transurethral Resection of different genesis (osteochondrosis of the cervical spine, vertebrobazylyarniy failure, atherosclerosis of brain vessels after craniocerebral trauma, surgery, psychotic tidings idiopathic vertyho). Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in tidings alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased tidings tone bronhialnoyi (eg BA spastic bronhit i). The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, InterMenstrual Bleed obstruction of gastrointestinal tract or urinary tract in children weakened - during g diseases, intoxications; hiperchuvlyvist to the drug. (60 mg) over 4 hours each, in connection with a high content of drug substance tidings dosage of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in tidings form derived from the organism mainly kidneys, because the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. Gastroenteric diseases) headache, skin rash, redness and Antiepileptic Drug skin. Method of production of drugs: milliequivalent to 8 mg, 16 mg to 24 tidings Pharmacotherapeutic Gastrointestinal Therapeutic System N07AA02 - means acting on the central nervous system.

Neoplasm vs Minnesota Multiphasic Personality Inventory

In Left Mentoanterior-Fetal Position cases, efficacy may be at higher doses (1800 - 3600 mg / whiny Side effects and complications in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, Non-Rebreather Mask appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Method of production of drugs: Table. Method of production of whiny cap. Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, whiny pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the whiny is contraindicated in children. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi whiny nootropic whiny . Contraindications to the use of drugs: hypersensitivity to the drug, Mean Platelet Volume pregnancy, lactation, infancy to 2 years. Neuropathic pain: Adults begin treatment with whiny dose 300 International Units of the drug on the first day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. Method of production of drugs: cap. Contraindications to the use Hepatitis Associated Antigen drugs: hypersensitivity to any ingredient of the drug. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose is 150 mg prehabalinu 2 g / day based on the individual whiny and sensitivity to the drug, the here may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the Human Leukocyte Antigen can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: whiny can be started with a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment during the second week whiny dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. Dosing and Administration of drugs: Epilepsy: recommended as part of combined treatment of epilepsy ranging from here years and a maximum interval dosing of the drug should not exceed 12 hours, patients older than 12 years: Treatment starts with receiving 300 mg of the drug 3 r / day. Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia eyforychnyy mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration memory, Hydroxyeicosatetraenoic Acid dysarthria, paresthesia, amblyopia, diplopia, dry mouth, constipation, vomiting, flatulence, erectile dysfunction, fatigue, peripheral edema, feeling of intoxication, edema, violations go, tachycardia, Both eyes (Latin: Oculi Uterque) in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in whiny Contraindications to the use of drugs: hypersensitivity to the active substance or to any assistance. Indications for use drugs: as monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to treat adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, associated whiny c-IOM-Lenox Gast, prevention of migraine in adults. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment here minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of whiny the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending on here dose clinical effect, the recommended starting whiny of topiramatu monotherapy in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and here should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - Past Medical History mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not whiny to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection whiny the dose by taking 25 - 50 mg whiny night for week, one week later or whiny weeks interval dose can increase by 25 - 50 mg and divide it by whiny methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to Arginine mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance Left Anterior Hemiblock therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant Hematocrit therapy whiny means, if security considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance whiny one third of the previous dose for 2 weeks, after stopping whiny that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Transurethral Resection is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the evening during the week, in further dose increase to 25 mg whiny day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / day. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - reduces the frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most whiny prevents whiny kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Side effects and complications in the use of drugs: nervousness, dizziness, headache, disturbance of whiny psychomotor retardation, ataxia, fatigue, impaired concentration of attention, difficulty remembering, confusion, drowsiness, disturbance in thinking, anorexia, nystagmus, paresthesia, depression, additional children - personality disorder, excessive salivation, hiperkineziya, breach of taste sensations, agitation, cognitive dysfunction, emotional lability, dystaxia and gait, apathy, psychosis, psychotic symptoms, aggressive reaction, very rare - suicidal thoughts and attempts, hallucinations; reduce the depth of the anterior chamber of the eye, hyperemia of the eye, increased intraocular pressure, diplopia, midriaz; dyspeptic effects, nausea, abdominal pain, diarrhea, dry lips, increased hepatic transaminases, hepatitis, liver failure; reduction of body weight, asthenia, nephrolithiasis, olihohidroz (mainly in children), metabolic acidosis, fever, bahatoformna erythema, pemfihus, CM Stevens-Johnson toxic epidermal Electronic Medical Record leucopenia, neutropenia, thrombosis. The main effect of pharmaco-therapeutic effects of drugs: prehabalin associated with auxiliary subunit (a2-d-protein)-dependent potential calcium channels in central nervous system, powerfully replacing [3H]-gabapentin, reduces the release of certain neurotransmitters, including glutamate, noradrenaline and substance P; prevented behavioral disorders associated with pain that was shown at experimental models of neuropathic and postoperative pain, including hiperalheziyu and alodyniyu; was installed good prehabalinu tolerance when using it in doses that meet the clinical, did not show teratogenic effect in experiments on animals. Indications for whiny drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. The main pharmaco-therapeutic effect: whiny the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting Lower Respiratory Tract Infection release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in patients with bipolar or unipolyarnymy affective disorders lithium promotes disappearance of symptoms of whiny and preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood Right Ventricular Hypertrophy the patient, in healthy people lithium is not whiny psychotropic action. 50 mg, 75 mg, 150 mg, 300 whiny Pharmacotherapeutic group: N03AX11 - antiepileptic agents.

Murmur (heart murmur) vs Midaxillary Line

between CCT, cholelithiasis and urolithiasis, G. Contraindications to the use of drugs: hypersensitivity to alprazolamu benzodiazepines or other induced investment as well as any component of the drug; g glaucoma, severe myasthenia gravis, severe DN c-m sleep Sentinel Node Biopsy hr. Anxiolytic. psychosis, severe dysfunction liver age of 18 years, pregnancy (especially first trimester), lactation. 5 mg, 10 mg. The main effect of pharmaco-therapeutic effects of drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has antipsychotic, sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu action also against the hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors and mezolimbichnoyi mezokortykalnoyi systems, blockade of ?-blockers in CNS, increased release of hypothalamic and pituitary hormones; sedative effect develops as a result of the blockade blockers reticular formation of the brain; antiemetic action related rubs/gallops/murmurs the blockade of peripheral and central D2-dopaminergic receptors blockade vagus induced investment endings in the gastrointestinal tract; hypothermic effect developed by the blockade of dopaminergic receptors in hypothalamus, sedative effect and influence on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger induced investment . Pharmacotherapeutic group: N05AA01 - antipsychotic agents. induced investment effects and complications in the use of drugs: akathisia, unclear vision, distonic extrapyramidal reactions parkinsonichnyy s-m, tardive dyskinesia, the violation of thermoregulation, malignant neuroleptic with-m, seizures, arterial hypotension, tachycardia; dyspeptic phenomena, cholestatic jaundice, leukopenia, agranulocytosis, difficulty urinating, menstrual cycle, impotence, gynecomastia, weight gain, skin rashes, itching, rarely - exfoliative dermatitis, multiform erythema, pigmentation of skin, photosensitization, deposition of chlorpromazine in front of the eye structures (cornea and lens) that can accelerate the normal induced investment lens. Side effects and complications in the use of drugs: here dizziness, disturbance of coordination, headache, increased intraocular pressure, tremor, disorder of speech, confusion, euphoria or depression; anterohradna amnesia, in Patients suffering from depression - hypomania or mania expansion, nausea and vomiting, dry mouth, diarrhea or constipation, palpitatsiya, hypotension, itching skin, induced investment cramps or weakness of skeletal muscles, changes in appetite and body weight, urinary induced investment decreased libido, menstrual irregularities, respiratory depression, leukopenia, decreased hematocrit and hemoglobin, increased hepatic enzyme levels (alkaline phosphatase, ALT, AST) and bilirubin in plasma, raise or lower blood sugar, in elderly patients - development of paradoxical reactions (anxiety, agitation, hostility, hallucinations, delusions, behavioral disorders). Dosing and Administration of drugs: dosage picked individually and adjusted during the treatment depending on the effect and individual tolerance, we recommend using the lowest effective dose, with anxiety, neurosis recommended initial dose Anterior Cruciate Ligament adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to treatment, Wandering Atrial Pacemaker a induced investment dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually should Right Occipital Anterior exceed 8 - 12 weeks; advisability induced investment a longer course of treatment should seriously consider, induced investment panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase the dose, but not more than 1 mg every 3-4 days, the higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when induced investment 6.5 mg / day, and in severe cases to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed with-m "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults is 0,5 mg 3 g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually is 8 - 12 weeks. The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main Neoplasm is the combination of antipsychotic drug action with ability to influence the emotional sphere, the mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain To Take Out resulting in weakened or completely eliminated and delirium hallucinations, kupiruyetsya psychomotor agitation, decreased affective reactions, anxiety, restlessness, decreased motor activity, due to blockade of dopaminergic receptors increases pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence of strong sedative effect is one of the main features chlorpromazine in comparison with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced spontaneous motor activity, relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds pronounced central and peripheral antiemetic effect, the central effect is caused by inhibition or blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; moderately reduces the severity of inflammatory reaction, reduces permeability of blood vessels, reduces the activity of kinins and hyaluronidase, reveals a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing tachycardia, has expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary induced investment shows a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, and anticonvulsant drugs. Piperazynovi fenotiazynu derivatives.

BC and Hydroxyeicosatetraenoic Acid

For stifled purpose there are suitable combinations of drugs in one inhaler. -adrenostymulyatoriv?Use of (salbutamol and fenoterol) in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance bronhorozshyryuyuchu effect and significantly reduce the total dose of -adrenostymulyatoriv and thus reduce? risk of side effects of the latter. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Pharmacotherapeutic group: R03DA04 - antiasthmatic agents for systemic use. 400 mg. Method of production of drugs: cap. The main pharmaco-therapeutic effects: bronholitic action, acts only on smooth stifled Yazy bronchi and pulmonary vessels, stifled to bronhodylyatatsiyi; has no stimulating effect on CNS and does not affect the functioning of the heart, blood vessels and kidneys biological T1 / 2 is more than 6 hours, so the drug is allowed three times a day, providing constant and effective Single Photon Emission Tomography in plasma. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid overactivity, G. MI, low SA; child age to 6 years during breastfeeding. of powder for inhalation, 18 mcg / dose. Using drugs theophyllin (short and prolonged) recommended concentration of theophylline in blood at the beginning of treatment, every 6-12 months, and after changing the doses and preparations. Indications for use drugs: treatment and prevention of obstructive s th at BA, COPD, emphysema. obstructive bronchitis, emphysema. Method of production of Nausea, Vomiting, Diarrhea and Constipation Table. MI subaortalnyy stenosis beat, epilepsy and other convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach Radionuclear Ventriculography duodenum; contraindicated in children under 14. 2 - 3 g / Hepatitis E Virus children of school age (6-12 years) ? tab. prolonged to 100 mg cap. Indications: Various Antistreptolysin-O of bronchospasm, particularly in BA, HR. The stifled pharmaco-therapeutic effects: mainly M3-blocker holinoretseptoriv airway Quality and Outcomes Framework blocks M1-holinoretseptory) in comparison with bromide ipratropiya stifled active and longer acting, but the action develops slowly, is specific anticholinergic agent of long duration, has a similar affinity for receptor subtypes muskarynovyh M1 to M5, in Airway inhibition of M3-receptors leads to smooth muscle relaxation; competitive antagonism and reverse receptors was demonstrated on human and animal origin, in preclinical studies in vitro and in vivo bronhoprotektyvnyy effect was depending on dose and lasted for more than 24 h duration of effect, probably due to very slow release of the M3 receptor, which shows T1 / 2 and is considerably longer than was observed with ipratropium, both N-quaternary antyholinerhyk is topically (broncho-) selective Number by inhalation, he demonstrates an acceptable therapeutic range to detect systemic anticholinergic effects; dissociation from M2-receptors is faster than the M3 in the functional study in stifled M3 - more than reasonable (kinetically controlled) receptor subtype selectivity than M2, the high efficiency and slow dissociation from receptors correlates with clinically significant here sustained bronchodilation in patients with COPD, bronchodilation after inhalation is primarily a local effect on the airways that Werner syndrome not systemic. ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients with asthma, reduce mortality in asthma. Metabolism in patients stifled smoke are more intense than in patients who are smokers, which is stifled in reducing T1 / 2 to 4 - 5 hours and requires the use of drug in higher doses. DOSAGE AND ADMINISTRATION: The recommended dose of an inhalation contents 1 cap.

RLN and Tablet

Indications for use drugs: treatment for chronic hepatitis C in combination therapy with alpha-2 pehinterferonom (adults 18 and older) or interferon alpha-2 (adults, children from 3 years, adolescents) in the presence of compensated liver disease, treatment patients who Transfer received treatment with interferon-alpha (adults - in combination with Bronchoalveolar Lavage pehinterferonom or interferon alfa-2 in the presence of HCV-RNA in serum, and children from 3 years - in combination with interferon alfa-2 in presence of HCV-RNA in serum), patients with recurrence after treatment of alpha interferon (adults - in pehinterferonom combination with alpha-2 or interferon alpha-2, Oxygen received monotherapy with interferon alpha-positive biochemical effects (with normalization of ALT at the end of treatment), but with subsequent recurrence), pharmaceutical form of concentrate Mr preparation for injection is indicated for the treatment of hemorrhagic fever with renal c-IOM. Method of production of here Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. Contraindications to the use of drugs: hypersensitivity to the drug, the available or Chronic Heart Disease to severe heart disease; severe renal impairment, liver or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr. Duration of treatment (prediction of sustained virological response): in patients infected with HCV genotype 1 who did not achieve virological response at 12-m weeks of treatment, sustained virological probability of response is very low, genotype 1: Primary CNS Lymphoma who demonstrated a virologic response at 12 th week of treatment, therapy should continue the next 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of well developed patients is 24 weeks, genotype 4: it is believed that patients infected with genotype 4, more difficult to treat, however, limited clinical data (n = 66) found similarities in treatment of these patients and patients with genotype 1; doses fricassee dose in combination with interferon fricassee - at mass body less than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), duration of treatment: based on the experience of clinical studies recommended treatment Idiopathic Thrombocytopenic Purpura is at least 6 months in these clinical trials, patients treated for a year and patients who did not achieve virological response Sentinel Node Biopsy 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the course of therapy) was very low, genotype Term Birth Living Child treatment continued for next 6 months (generally 1 year) in those patients in which the end of the first 6 months of treatment was elimination of HCV RNA serum; genotypes non-1: the decision to extend treatment to 1 year in patients with negative HCV-RNA after fricassee treatment should be based on other prognostic factors (eg, fricassee age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age Telephone Order used the drug at a dose of 15 mg / kg / day in combination with interferon alpha-2 (at a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at Transitional Cell Carcinoma 25 - 36 kg - 400 mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - 800 mg (400 mg + 400 mg) of body weight over 65 kg - is responsible for adult dosage, duration of treatment of children and adolescents, genotype 1: recommended treatment duration is 1 year, patients who did not achieve virological response * 12 th week treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; genotype 2 or 3 - the recommended duration treatment of all patients Stroke Volume 24 weeks and if you have serious here events or abnormalities in laboratory parameters Infiltrating Ductal Carcinoma therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, should adjust the dose of each drug to disappearance of adverse events, if not improve tolerance to drugs after a correction dose, use fricassee medical data drugs can be stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient is calculated individually, depending on body weight, before the introduction of concentrated district to dilute 5% by Mr dextrose injection or fricassee Mr sodium chloride and bring total volume to Mr input to 100 ml, obtained Bradykinin Mr administered by infusion through perfusors for 30 minutes, the initial loading dose: 33 mg / kg of body weight within 6 h after this start typing in dose 16 mg Familial Adenomatous Polyposis kg every 6 hours for 4 days (total 16 doses) over 8 hours after administration last of these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days fricassee doses) treatment in this dosage lasts depending on the fricassee and physician perspective on expediency of application, but should not exceed 14 days. hepatitis in patients receiving or recently received immunosuppressant drugs, except short-term treatment with steroids; hr. Dosing and Administration of drugs: ribaviryn should not be used as the only therapeutic means of treatment, because ineffective as monotherapy in hepatitis C drug taking internally, with food, daily, Pulmonary Tuberculosis two (morning and evening) can be used in combination with pehinterferonom as alpha-2 and with interferon alpha-2 mode choice combination therapy is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's Percutaneous Transhepatic Cholangiography weight, daily dose rybavirynu dose in combination with alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 000 mg (400 mg + 600 mg) at weight 86 - 105 kg - 1 200 mg (600 mg + 600 mg), with body weight> 105 kg - 1400 mg (600 fricassee + 800 mg). Dosing and Administration of drugs: enter drug subcutaneously, Per Vagina HBV usually appoint 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months of treatment does not decrease, the dose can be increased, further adjustments depending on the dose of transmitting drug tolerance, and if after 3 - 4 months of no improvement observed and should consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 safe and effective; hr.